Using ctDNA to predict recurrence and response in colorectal cancer

12:22 EDT 15 Jul 2019 | ecancermedicalscience

Dr Aparna Parikh speaks to ecancer at ESMO 21st World Congress on Gastrointestinal Cancer about using cell-free circulating tumour DNA (ctDNA) to predict recurrence and response in colorectal cancer patients during adjuvant and neoadjuvant therapy. She...

Original Article: Using ctDNA to predict recurrence and response in colorectal cancer

More From BioPortfolio on "Using ctDNA to predict recurrence and response in colorectal cancer"